z-logo
open-access-imgOpen Access
Heroin (Opioid) Treatment
Author(s) -
Jamshid Ahmadi
Publication year - 2016
Publication title -
juniper online journal of case studies
Language(s) - English
Resource type - Journals
ISSN - 2476-1370
DOI - 10.19080/jojcs.2016.01.555562
Subject(s) - heroin , opioid , medicine , anesthesia , pharmacology , drug , receptor
Heroin is one of the derivative of morphine and also an opioid mu receptor agonist that was earlier presented as a non-addictive medication. Buprenorphine was accepted by the Food and Drug Administration (FDA) for the management of heroin withdrawal symptoms. Buprenorphine is considered as a partial mu agonist and also a secure drug with low chance of toxicity and overdose [1]. For the therapy of heroin dependence, buprenorphine is more useful than methadone [2-4]. Investigators such as Johnson, Jaffe, and Fudaladescribed that 8mg of sublingualbuprenorphine per day is equal to 60mg of methadone considering retention rates and opioids negative urines as well [5]. Buprenorphinecan diminish the incidence of HIV and other connected disorders following opioidsconsumption [1,6-8].

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom